The global surgical instrument market size was USD 18.98 Billion in 2021 and is expected to register a revenue CAGR of 8.0% during the forecast period. Increasing prevalence of different chronic diseases such as cardiovascular diseases, cancer, and neurological disorders, and rising number of accidents and trauma emergencies, are key factors driving market revenue growth. Surgical instruments are portable tools used by physicians and other health care professionals to change, hold, clamp, cut, retract, dilate biological tissue, or provide access for observing it. In addition, these tools are used to get access to soft tissue, dissect lesions, or remove bone. Some of the most commonly used surgical instruments are scalpels, scissors, forceps, clamps, and retractors. These instruments come in a variety of sizes and are often constructed of carbon steel, aluminum, stainless steel, plastic, and polymers.
In the field of surgical instruments, there has been a significant growth in cost-effective medical equipment and high-performance components for greater productivity and efficiency during the past few years. OEMs have used medical-grade plastics as a realistic, inventive alternative to traditional metal equivalent to provide easier processability with equivalent or enhanced functionality. Modern surgical equipment needs plastics with superior strength, stiffness, and mechanical performance to compete with and outperform conventional metals. Plastics provide both disposable and reusable surgical tools with exceptionally high tensile and flexural strength, allowing for superior stiffness and mechanical stress resistance. These high-performance medical-grade resins retain their toughness and impact resistance after severe surgical operations, lengthy chemical exposure, and high-temperature steam sterilizing techniques. Medical-grade plastics are rapidly becoming the material of choice for a variety of surgical instruments. Moreover, use of plastic in surgical instruments offers various advantages including reduced cost, enhanced ergonomics, and enhanced functionality. Polymers provide remarkable sterilization resilience as well as chemical resistance, allowing reusable surgical tool plastics to withstand over a thousand cycles of steam sterilization or autoclaving without suffering substantial performance degradation.
Request a Sample@ https://qyresearchmedical.com/sample/119091
The CDC Healthcare-Associated Infection (HAI) Prevalence Survey found that inpatient surgeries caused about 110,800 Surgical Site Infections (SSIs). Based on HAI data results for 2020 that were published in NHSN’s HAI Progress Report, SSI Standardized Infection Ratio (SIR) for all NHSN operative procedure categories decreased by about 5% in 2020 compared to the previous year. In 2020, it was said that SIR related to Surgical Care Improvement Project (SCIP) NHSN operative procedure categories had dropped by about 5% compared to the previous year. In both public and private hospitals, total frequency of surgical site infections was 9.9, which were found in 13.4% of public hospitals and 6.5% of private hospitals.
Driver: Launch of novel products and rise in number of surgical procedures are driving surgical instruments market revenue growth
The global population is registering a substantial increase in life expectancy, which is expected to lead to a rise in chronically ill individuals. To meet the needs of an aging population, search for superior medical services and products has become a global priority. Today’s modern surgical methods are expanding rapidly within a highly sophisticated healthcare setting. The market for powered surgical instruments is undergoing revolutionary and novel developments, particularly for neurosurgical, ophthalmology, orthopedic, oral, and cardiac operations. Surgeons are constantly in search of higher-quality devices that enable them to conduct a variety of surgical operations fast and efficiently without compromising patient safety. New and improved designs of powered surgical drills and screwdrivers are introduced each year, enabling unprecedented levels of control, precision, and performance in the operating room. Moreover, these screwdrivers are utilized for delicate treatments, such as neurosurgery, to treat brain tumors or accident-related brain injuries. Another current surgical instrument trend, space technologies, continues to find uses in medical field, notably through increasing endoscopic vision and producing 3D pictures with great resolution. This is expected to provide a broader application of laparoscopic procedures in neurosurgery.
Restraint: High cost of reusable surgical instruments is a key factor restraining market revenue growth
When selecting medical equipment to invest, its related maintenance cost is an important consideration. After every surgery, reusable surgical instruments should undergo sterilization & reprocessing, which is not reflected in their initial price. Charge for sterilization will include fee for transportation of equipment to sterilizing facility, cost of sterilization chemicals, fee for repackaging, and cost of manpower to complete the sterilization procedure. Median hourly wage for a sterile processing specialist is USD 20, but sterilization can sometimes cost as much as USD 10 per tool. Taking into account all of these aspects, cost of reusing an instrument might be much more than the cost of using and replacing a disposable instrument.
The global spread of a novel coronavirus illness (COVID-19) has led to a near-complete stoppage of non-urgent, elective surgeries across all professions in majority of afflicted countries, negatively impacting the industry. Many cosmetic surgeons throughout the world have self-imposed a suspension of all aesthetic surgical procedures recommended by major international scientific organizations, resulting in a severe economic impact on most medical centers. Cancellation of elective procedures has a substantial impact on individuals and has cumulative, potentially devastating repercussions for global healthcare systems, restricting market revenue growth. Postponing time-sensitive elective operations, such as cancer or transplant surgery, leads to poor health, worse quality of life, and avoidable deaths. When hospitals resume elective activities, patients are expected to be prioritized based on clinical urgency, resulting in lengthier delays for patients with benign but potentially debilitating conditions, where perceived time effect is lower. As a result, public health is expected to deteriorate, with substantial socioeconomic consequences.
However, important surgical operations were retained during pandemic by conducting swift situational inspections and devising localized strategies that took into account pandemics’ constraints while guaranteeing patient and staff safety, which hampered market development. The clinic’s ongoing provision of urgent and emergency hand surgery services led to a rise in postoperative follow-up patients. Cases managed by emergency medicine (ED) physicians were also referred to hand clinic for further evaluation. These are factors that hindered market growth during COVID-19.
Product Type Insights:
Based on product type, the global surgical instruments market is segmented into surgical sutures and staplers, handheld surgical devices, and electrosurgical devices. The handheld surgical devices segment is further segmented into forces & spatulas, refractors, dilators, graspers axillary instruments, and cutter instruments. The surgical sutures segment is expected to register a rapid revenue growth rate during the forecast period. One of the most common tools used by doctors during surgery is a surgical suture. When someone has surgery or gets hurt, the suture helps to hold body’s tissues together. Sutures are typically applied with a needle and a thread that is connected to it. Currently, doctors can use a wide range of surgical sutures with different sizes, shapes, and types of thread. A micro needle holder is used in conjunction with micro forceps and surgical microscope to hold a needle while cornea, sclera, and conjunctiva are sewed together. Additionally, the treatment rooms of ophthalmology outpatient clinics and wards, include treatments such as suture removal, foreign body extraction from cornea, trichiasis removal, and punctual dilation. In front of a slit lamp microscope, corneal, and conjunctival sutures can be removed with a syringe needle and micro syringe holder instead of micro forceps.
The electrosurgical devices segment is expected to register a moderate revenue growth rate during the forecast period. Electrosurgical is a surgical instrument used to incise tissue, damage tissue by desiccation, and halt bleeding (hemostasis) by inducing blood to coagulate. A high-powered & high-frequency generator creates a Radiofrequency (RF) spark between a probe as well as surgical site, causing localized heating and tissue damage. Electro surgery has a wide range of applications, including treating cutaneous lesions in dermatology, sterilizing root canals in dentistry, closing incisions in eye surgery, and allowing laparoscopic processes in gynecological and gastrointestinal surgeries, among others. Researchers note that many of today’s surgical treatments and methods owe their existence and success to RF as a result of electro surgery’s adaptability and unique benefits.
Based on application, the global surgical instrument market is segmented into neurosurgery, obstetrics & gynecology, wound closure, cardiovascular, plastic & reconstructive surgery, orthopedic, laparoscopy & others. The neurosurgery segment is expected to register a rapid revenue growth rate during the forecast period. Neurosurgery treats the nervous system, which includes brain, peripheral nerves, extracranial cerebrovascular system, and spine. Neurosurgery operations include neuro-oncology to treat brain cancers, cerebrovascular to treat strokes and Arteriovenous Malformations (AVM), epilepsy treatments, and trigeminal neuralgia procedures to alleviate nerve compression. Common neurosurgical instruments include traditional & bipolar forceps, curettes, dissectors, and clamps. Neurosurgeon-led discoveries have resulted in creation of novel medications, imaging modalities, instruments, and technologies that enhance patient care throughout the past several decades. Novel techniques of diagnosis detection, intracavitary medication treatments, and vaccination therapies are examples of patents in the field of brain tumors. Also, with emergence of Gamma Knife (Electa, Stockholm, Sweden) and CyberKnife (Accuray Incorporated, Sunnyvale, California), image-guided Stereotactic Radiosurgery (SRS) has given targeting cranial and spinal lesions with greater sensitivity and efficiency than standard external beam radiation therapy, with excellent long-term results. Medtronic implanted electrodes (Medtronic plc, Dublin, Ireland) were used to treat a variety of conditions such as chronic pain, cerebral palsy, and epilepsy. The Food and Drug Administration (FDA) recently certified SynchroMed (Medtronic) as an implanted device that distributes medicine intrathecally for management of chronic pain. These are just a few instances of how innovation is being utilized to better neurosurgery.
The cardiovascular segment is expected to register a steady revenue growth rate during the forecast period. As global prevalence of heart illness rises, so does the rate of discovery of new treatments. Microsurgical instruments, such as scissors, needle holders, clamps, dilators, rongeurs, tourniquets, vein passers, instruments for minimally invasive surgery, specialty retractor systems, rib as well as sternum retractors, valve retractors, and others, are among cardiovascular surgical instruments. Cardiovascular surgical tools manufacturers currently provide a diverse range of specialized adult cardiovascular surgical equipment packages that are designed to fulfill demanding requirements of today’s cardiovascular surgeons. Cardiovascular surgical instrument producers face stringent quality standards, precision craftsmanship, and designs that convert into novel microsurgical devices for accurate cardiovascular treatments.
Based on category, the global surgical instruments market is segmented into reusable and disposable. The disposable segment is expected to register a steady revenue growth rate during the forecast period. When a healthcare facility receives a pre-sterilized instrument, neither decontamination nor a long sterilization process is required, saving the facility money. In addition, after a tool has been used, disinfected, and stored, its cleanliness cannot be determined. Disposable, one-time-use equipment guarantees the ability to account for every inventory item and provide complete traceability. Each piece’s lot number may be tracked back to a medical manufacturing facility to prevent discrepancies and problems.
The reusable segment is expected to register a steady revenue growth rate during the forecast period. Reusable medical equipment, such as surgical forceps, endoscopes, and stethoscopes, can be reprocessed and utilized on many patients. These instruments are intended and labeled for numerous usage and are reprocessed between patients by thorough cleaning consisting of high disinfection or sterilization. They are constructed with materials that can endure frequent reprocessing including manually brushing and chemical usage.
Based on regional analysis, the Asia Pacific market is expected to register fast CAGR during the forecast period owing to surge in prevalence of chronic diseases, growing number of accidents and surgical procedures, rising cost of healthcare, and increasing demand for most advanced surgical tools and technology. Moreover, growing expenditures in research & development efforts to produce sophisticated and cheap surgical tools are expected to drive market revenue growth in Asia Pacific over the forecast period. Indian Healthcare business has grown substantially over the past decade and is now on a strong development trajectory. The existing demand and supply dynamics provide ample potential and justification for production of medical equipment in India. The Government of India’s ‘Make in India’ program provides a forum for the sector to reassess operating model, identify critical imperatives for growth, and investigate potential for a step shift in the medical devices industry.
The North America market accounted for a significant revenue share in 2021. Development of modern technologies, such as a robotic handheld surgical instrument, for laparoscopic operations increases dexterity of a surgeon. Necessity for high dependability, precision, and patient safety has encouraged various advancements. New cordless portable gadgets are one invention that has increased surgeons’ comfort and control.
The Europe market accounted for a significant revenue share in 2021 as a result of increase in traffic accidents, chronic illnesses such as cancer, autoimmune diseases, and blood disorders, increase in number of operations throughout the region, high output of disposable equipment, and presence of well-established healthcare facilities and infrastructure. Rapid advancements in surgical equipment, increased demand for portable devices and minimally invasive surgery instruments, and escalating spending in research & development activities are all influencing growth of the industry. Germany is the leading manufacturer of surgical tools in Europe, with a 25% market share, followed by Belgium at 18% and the Netherlands at 12%. For instance, KLS Martin Group, particularly in the highly advanced field of neurosurgery, provides maximum assistance to its clients through a constantly expanding product portfolio that includes both cranial and spinal solutions.
Competitive landscape of global surgical instruments market is fragmented with many key companies operating on global and regional levels. Key players are engaged in product development and strategic alliances to expand their respective product portfolios and gain a robust footing in the global market. Major companies in the market include Smith+Nephew, Zimmer Biomet, B. Braun Melsungen AG, Stryker, Dextera Surgical Inc., Aspen Surgical., Alcon, BD, Medtronic, and Boston Scientific Corporation.
Initiatives taken by companies are driving growth of the market, for instance:
On 24th November 2020, Aspen Surgical, an industry leader in production of disposable surgical products purchased Protek Medical Products. This acquisition is expected to expand Aspen’s surgical product range by adding the unique pull-up probe cover technology from Protek.
On 1st December 2020, Zimmer Biomet, a global leader in musculoskeletal healthcare, announced to purchase A&E Medical Corporation. This acquisition is expected to increase production of sternal closure devices and equipment, single-use complimentary temporary pacing wire, and surgical punch devices, as well as fulfill unmet patient and surgical demands.
Segments Covered in the Report
This report offers historical data and forecasts revenue growth at a global, regional, and country-level and provides analysis of the market trends in each of the sub-segments from 2022 to 2030. For this study, Reports and Data have segmented the surgical instruments market based on product type, application, category, and region:
Surgical Instruments Market Report Scope
Segments covered By Product Type Outlook, Application Outlook, Category Outlook, Regional Outlook
By Product Type Outlook
Surgical Sutures & Staplers
Handheld Surgical Devices
Forces & Spatulas
By Application Outlook
Obstetrics & Gynecology
Plastic & Reconstructive Surgery
By Category Outlook
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://qyresearchmedical.com/report/checkout/119091/1500
You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/